14th October 2008

NovaBiotics attends ICAAC 2008

The level of interest from the pharmaceutical and biopharmaceutical sector in the Novexatin^® asset was made very clear at the key annual industry event for the anti-infectives sector, the 48th Interscience Conference on Antimicrobial Agents and Chemotherapies (ICAAC). NovaBiotics' business development consultant and senior scientists held very useful one-to-one meetings during the event at which the Company was able to update a number of its potential commercial partners with the latest data and plans for the compound's continued development and commercialisation.